ASTROTECH Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
ASTROTECH Corp (ASTC) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $15.80 per share for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-09-26
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2025 was $15.80, a 35.86% increase from fiscal 2024.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2024 was $11.63, a 42.48% decline from fiscal 2023.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $20.22, a 21.63% decline from fiscal 2022.
- ASTROTECH Corp share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $25.80, a 975.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|
| 2025-06-30 | $15.80 10-K · filed 2025-09-26 | |
| 2024-06-30 | $11.63 10-K · filed 2025-09-26 | |
| 2023-06-30 | $20.22 10-K · filed 2024-09-20 | |
| 2022-06-30 | $25.80 10-K · filed 2023-09-28 | $0.86 10-K · filed 2022-09-15 |
| 2021-06-30 | $2.40 10-K · filed 2022-09-15 | |
| 2020-06-30 | $2.42 10-K · filed 2021-09-21 | |
| 2019-06-30 | $3.01 10-K · filed 2020-09-08 | |
| 2018-06-30 | $2.83 10-K · filed 2019-09-30 | |
| 2017-06-30 | $6.15 10-K · filed 2018-09-25 | $1.23 10-K · filed 2017-09-18 |
| 2016-06-30 | $1.18 10-K · filed 2017-09-18 | |
| 2015-06-30 | $0.70 10-K · filed 2016-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |